<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03606798</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX2015/06</org_study_id>
    <nct_id>NCT03606798</nct_id>
  </id_info>
  <brief_title>Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.</brief_title>
  <acronym>DLFT</acronym>
  <official_title>Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fronto-Temporal Lobar Degeneration (FTLD) refers to 3 categories of neurodegenerative&#xD;
      diseases generally occurring between 55 and 65 years: Fronto-Temporal Dementia(FTD), Primary&#xD;
      Progressive Aphasia (PPA), Semantic Dementia (SD). Clinical expression is substantially&#xD;
      variable among individuals, but in most cases, behavioural disorders and personality changes&#xD;
      are prominent. FTLD is poorly known by general public including health care professionals.&#xD;
      Currently, the French health system does not meet the needs and expectations of patients and&#xD;
      their families&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with FTLD and their caregivers need to be recognized and supported through specific&#xD;
      and tailored made actions provided by expert teams. The main objective of our study is to&#xD;
      evaluate the effectiveness of a 6-month personalized multidisciplinary care provided to the&#xD;
      dyad FTLD patient and caregiver on patient's behavioural disorders. The secondary objectives&#xD;
      are to assess the impact of this program on patient's cognitive deterioration, functional&#xD;
      autonomy and behavioral problems, as well as caregiver's depressive symptomatology and sense&#xD;
      of competence&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2018</start_date>
  <completion_date type="Anticipated">June 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of neuropsychiatric symptomatology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of neuropsychiatric symptomatology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Mental State Examination</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frontal Behavioral Inventory</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frontal Assessment Battery</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale Score ( From 0 to 30)</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Score : 0 - 5 : normal Score : 5 - 9 : light depression Score : 10 - 30 : severe depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sense of Competence Questionnaire (SCQ)</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire (QoL-AD)</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hierarchical scale of internality for elderly people (EHIPA) score ( From 0 to 22)</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>The score varies from 0 to 22. A high score corresponding to an important internality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Frontotemporal Lobar Degeneration</condition>
  <arm_group>
    <arm_group_label>Multidisciplinary and personalized care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Personalized care and proposals bring by a team of experts : neurologists ; geriatrician ; psychologist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard clinical evaluations of patient with Frontotemporal Lobar Degeneration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 Home visits made by a psychologist</intervention_name>
    <description>Patient and caregiver interviews with a psychologist at home</description>
    <arm_group_label>Multidisciplinary and personalized care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        Patients&#xD;
&#xD;
          -  Fronto-Temporal Lobar Degeneration diagnoses&#xD;
&#xD;
          -  Men or women aged 18 and over&#xD;
&#xD;
        Caregiver&#xD;
&#xD;
        • Spouse, brother, sister, child living at patient's home and can provide the medical team&#xD;
        of reliable information on the status of their parent.&#xD;
&#xD;
        Exclusion criteria :&#xD;
&#xD;
        Patient&#xD;
&#xD;
          -  Patient institutionalized&#xD;
&#xD;
          -  Pregnant or breast-feeding woman&#xD;
&#xD;
          -  Psychotic syndrome&#xD;
&#xD;
          -  Severe and unstable general medical condition&#xD;
&#xD;
          -  Patient bedridden&#xD;
&#xD;
        Caregiver&#xD;
&#xD;
          -  Persons under legal protection&#xD;
&#xD;
          -  Severe and unstable general medical condition&#xD;
&#xD;
          -  Pregnant or breast-feeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François DARTIGUES</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie AURIACOMBE</last_name>
    <phone>05 57 82 12 53</phone>
    <email>sophie.auriacombe@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène AMIEVA</last_name>
    <phone>05 57 57 15 10</phone>
    <email>helene.amieva@u-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie AURIACOMBE</last_name>
      <phone>05 57 82 12 53</phone>
      <email>sophie.auriacombe@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hélène AMIEVA</last_name>
      <phone>05 57 57 15 10</phone>
      <email>helene.amieva@u-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Frontotemporal Lobar Degeneration</keyword>
  <keyword>Behavioral disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

